Heart failure & cardiomyopathies
Self-Efficacy and Healthcare Costs in Patients with Chronic Heart Failure or Chronic Obstructive Pulmonary Disease
Authors' conclusion
The findings show that an increased or sustained self-efficacy is associated with lower direct costs in patients with CHF or COPD.
Study context
- Population
- Patients hospitalized for worsening chronic heart failure (CHF), chronic obstructive pulmonary disease (COPD) or bothremaining at 6-month follow-up
- Participants
- 118 vs 103
- Comparison
- Self-efficacy trajectories and direct healthcare costs
- Controln = 118reference
- Interventionn = 103
- Primary endpoint
- Association between self-efficacy trajectories and direct costs (healthcare and drug expenditures)
Methodological detailsopen, stratified randomisation, group-based trajectory modelling, linked register data, Conducted January 2015 to November 2016
- Open
- Stratified randomisation
- Group-based trajectory modelling
- Linked register data
- Conducted January 2015 to November 2016
Primary result
As reported in the abstract
Direct costs by self-efficacy trajectory
- Increasing or stable self-efficacy associated with lower direct costs
- P = 0.0013
Original publication
Self-Efficacy and Healthcare Costs in Patients with Chronic Heart Failure or Chronic Obstructive Pulmonary Disease. ESC Heart Fail. Published 8 November 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →